Pesquisas alternativas:
development types » development type (Expandir a Pesquisa), development times (Expandir a Pesquisa), development time (Expandir a Pesquisa)
dose development » dose developmental (Expandir a Pesquisa), mouse development (Expandir a Pesquisa), house development (Expandir a Pesquisa)
models develop » model develop (Expandir a Pesquisa), models developed (Expandir a Pesquisa), model develops (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug models » drug mode (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
A mostrar 1 - 20 resultados de 603 para a pesquisa '(( drug dose development types ) or ( drug models develop type ))', tempo de pesquisa: 1.01seg Refinar resultados
Short Communication: A Repeated Simian Human Immunodeficiency Virus Reverse Transcriptase/Herpes Simplex Virus Type 2 Cochallenge Macaque Model for the Evaluation of Microbicides
Oxazolone-Induced Delayed Type Hypersensitivity Reaction in the Adult Yucatan Pigs. A Useful Model for Drug Development and Validation

Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
Analysis of Drug Development Paradigms for Immune Checkpoint inhibitors

Development of drug resistance in a murine mammary tumour.
Development of an Optimized Dose for Coformulation of Zidovudine with Drugs That Select for the K65R Mutation Using a Population Pharmacokinetic and Enzyme Kinetic Simulation Model

Alzheimer’s Disease Drug Development in 2008 and Beyond: Problems and Opportunities
Drug permeation and metabolism in Mycobacterium tuberculosis: prioritising local exposure as essential criterion in new TB drug development

Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
The evaluation of different types of anti-convulsant drug activity against leptazol-induced epileptogenic activity in the anaesthetized rat.

Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study
Repurposing the anticancer drug cisplatin with the aim of developing novel Pseudomonas aeruginosa infection control agents

Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development
Development of a Novel In Vitro Human Tissue-Based Angiogenesis Assay to Evaluate the Effect of Antiangiogenic Drugs

Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization
Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs

Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model‐based meta‐analytic approach
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia

A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist with Preclinical Efficacy for Psychoses
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development

Ferramentas de pesquisa: Obter Feed RSS — Enviar pesquisa por email — Guardar a pesquisa